MedTrace Logo

Low Voltage-Directed Catheter Ablation for Atrial Fibrillation

NCT03355456 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2024-06-10

No results posted yet for this study

Summary

A two-pronged approach to evaluate long term success of non-paroxysmal ablation when using a:

1. specified low voltage-directed with pulmonary vein isolation (LD+PVI) approach compared to ,
2. an approach of pulmonary vein isolation (PVI) alone.

Conditions

  • Atrial Fibrillation - Symptomatic

Interventions

PROCEDURE

Radiofrequency ablation

Ablation procedure to eliminate atrial fibrillation

Sponsors & Collaborators

  • Biosense Webster, Inc.

    collaborator INDUSTRY

  • Ohad Ziv

    lead OTHER

Principal Investigators

  • Ohad Ziv, MD · MetroHealth System, Ohio

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-14
Primary Completion
2026-05-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03355456 on ClinicalTrials.gov